Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: Effects of antiretroviral therapy

AIDS Research and Human Retroviruses

Volumn 24, Issue 11, 2008, Pages 1375-1382

  Van Den Bout Van Den Beukel, Carolien J P ^a   Fievez, Lydia ^a   Michels, Meta ^a   Sweep, Fred C G J ^a   Hermus, Ad R M M ^a   Bosch, Marjolein E W ^a   Burger, David M ^a   Bravenboer, Bert ^b   Koopmans, Peter P ^a   Van Der Ven, André J A M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CATHARINA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CALCIFEDIOL; PARATHYROID HORMONE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BONE METABOLISM; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOREGULATION; INDEPENDENT VARIABLE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NETHERLANDS; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SKIN COLOR; SKIN PIGMENTATION; UNIVARIATE ANALYSIS; VITAMIN D DEFICIENCY;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PARATHYROID HORMONE; PREVALENCE; RISK FACTORS; SKIN PIGMENTATION; VITAMIN D DEFICIENCY;

EID: 57049084662     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2008.0058     Document Type: Article

References (26)

1. Amorosa V and Tebas P: Bone disease and HIV infection. Clin Infect Dis 2006;42(1):108-114.
2. Brown TT and Qaqish RB: Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS 2006;20(17):2165-2174.
3. Haug C, Muller F, Aukrust P, and Froland SS: Subnormal serum concentration of 1,25-vitamin D in human immunodeficiency virus infection: Correlation with degree of immune deficiency and survival. J Infect Dis 1994;169(4):889-893.
4. Nieto G, Barber Y, Rubio MC, Rubio M, and Fibla J: Association between AIDS disease progression rates and the Fok-I polymorphism of the VDR gene in a cohort of HIV-1 seropositive patients. J Steroid Biochem Mol Biol 2004;89-90(1-5):199-207.
5. Haug CJ, Aukrust P, Haug E, et al.: Severe deficiency of 1,25-dihydroxyvitamin D3 in human immunodeficiency virus infection: Association with immunological hyperactivity and only minor changes in calcium homeostasis. J Clin Endocrinol Metab 1998;83(11):3832-3838.
6. Teichmann J, Stephan E, Discher T, et al.: Changes in calciotropic hormones and biochemical markers of bone metabolism in patients with human immunodeficiency virus infection. Metabolism 2000;49(9):1134-1139.
7. Villamor E: A potential role for vitamin D on HIV infection? Nutr Rev 2006;64(5 Pt 1):226-233.
8. Holick MF: The cutaneous photosynthesis of previtamin D3: A unique photoendocrine system. J Invest Dermatol 1981;77(1):51-58.
9. Omdahl JL, Bobrovnikova EA, Choe S, Dwivedi PP, and May BK: Overview of regulatory cytochrome P450 enzymes of the vitamin D pathway. Steroids 2001;66(3-5):381-389.
10. Beadle PC, Burton JL, and Leach JF: Correlation of seasonal variation of 25-hydroxycalciferol with UV radiation dose. Br J Dermatol 1980;103(3):289-293.
11. Bischof MG, Heinze G, and Vierhapper H: Vitamin D status and its relation to age and body mass index. Horm Res 2006;66(5):211-215.
12. Lips P: Vitamin D physiology. Prog Biophys Mol Biol 2006;92(1):4-8.
13. Cozzolino M, Vidal M, Arcidiacono MV, et al.: HIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin D. AIDS 2003;17(4):513-520.
14. Brodie MJ, Boobis AR, Dollery CT, et al.: Rifampicin and vitamin D metabolism. Clin Pharmacol Ther 1980;27(6):810-814.
15. Brodie MJ, Boobis AR, Hillyard CJ, et al.: Effect of rifampicin and isoniazid on vitamin D metabolism. Clin Pharmacol Ther 1982;32(4):525-530.
16. Valsamis HA, Arora SK, Labban B, and McFarlane SI: Antiepileptic drugs and bone metabolism. Nutr Metab (London) 2006;3:36.
17. CDC: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992;41(RR-17).
18. Voedingscentrum: Nederlandse Voedingsmiddelentabel, 40 ed. Voedingscentrum, Den Haag, 2004
19. Battegay M, Nuesch R, Hirschel B, and Kaufmann GR: Immunological recovery and antiretroviral therapy in HIV-1 infection. Lancet Infect Dis 2006;6(5):280-287.
20. Coodley GO, Coodley MK, Nelson HD, and Loveless MO: Micronutrient concentrations in the HIV wasting syndrome. AIDS 1993;7(12):1595-1600.
21. Kuehn EW, Anders HJ, Bogner JR, et al.: Hypocalcaemia in HIV infection and AIDS. J Intern Med 1999;245(1):69-73.
22. Lips P: Vitamin D status and nutrition in Europe and Asia. J Steroid Biochem Mol Biol 2007;103(3-5):620-625.
23. Grootjans-Geerts I and Wielders JP: [A pilot study of hypovitaminosis D in apparently healthy, veiled, Turkish women: severe vitamin D deficiency in 82%]. Ned Tijdschr Geneeskd 2002;146(23):1100-1101.
24. Grootjans-Geerts I: [Hypovitaminosis D: A veiled diagnosis]. Ned Tijdschr Geneeskd 2001;145(43):2057-2060.
25. Ramayo E, Gonzalez-Moreno MP, Macias J, et al.: Relationship between osteopenia, free testosterone, and vitamin D metabolite levels in HIV-infected patients with and without highly active antiretroviral therapy. AIDS Res Hum Retroviruses 2005;21(11):915-921.
26. Madeddu G, Spanu A, Solinas P, et al.: Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy. Q J Nucl Med Mol Imaging 2004;48(1):39-48.